In addition, metformin inhibits hexokinase (HK) in breast cancer cells, which is an essential glycolytic enzyme that catalyzes the phosphorylation of glucose by ATP to glucose-6-phosphate (G6P). Here, HK1 is linked to breast carcinoma.